Skip to main content
Premium Trial:

Request an Annual Quote

Roche Sells a 454 GS20 Sequencer to South African Biotech

NEW YORK (GenomeWeb News) — Roche e today said it has sold a 454 Life Sciences GS20 sequencer to the South African company Inqaba Biotechnical Industries. The deal includes the option to upgrade to a GS FLX.
 
Roche Diagnostics said it will provide Inqaba with support for the GS20’s applications.  
 
Inqaba said it was supported by BioPAD, a South African government-funded trust and shareholder designed to create a sequencing service in the region.
 
The Pretoria-based Inqaba was established in 2002 with start-up funding from the US, Germany, and Switzerland.
 
Roche said Inqaba’s customer base includes several other African countries.
 
Financial terms of the deal were not released.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.